Crinetics Pharmaceuticals’ Post

This World NETs Cancer Day, we reaffirm our commitment to people living with neuroendocrine tumors (NETs). We were proud to meet with clinical leaders and patient advocacy partners in the NETs space at the recent NANETs meeting to explore how we can continue advancing science for those impacted by NETs. Learn more about how we’re driving innovating in this space: https://bit.ly/3XbsFVK #WorldNETsDay #NeuroendocrineTumors

  • No alternative text description for this image

To view or add a comment, sign in

Explore content categories